Orange Book product
NAFCILLIN SODIUM EQ 500MG BASE/VIAL
Orange Book ANDA 062844 · WATSON LABORATORIES INC · Discontinued
Key facts
| Proprietary name | NAFCILLIN SODIUM |
|---|---|
| Active ingredients | NAFCILLIN SODIUM |
| Strength | EQ 500MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | ANDA062844 |
| Applicant holder | WATSON LABORATORIES INC |
| Marketing status | Discontinued |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Oct 26, 1988 |
At a glance
- None Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.